Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients

There is still debate over how reviewing oncological histories and addressing appropriate therapies in multidisciplinary team (MDT) discussions may affect patients’ overall survival (OS). The aim of this study was to describe MDT outcomes for a single cancer center’s patients affected by colorectal...

Full description

Bibliographic Details
Main Authors: Flavio Milana, Simone Famularo, Antonio Luberto, Lorenza Rimassa, Marta Scorsetti, Tiziana Comito, Tiziana Pressiani, Ciro Franzese, Dario Poretti, Luca Di Tommaso, Nicola Personeni, Marcello Rodari, Vittorio Pedicini, Matteo Donadon, Guido Torzilli
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/16/3952
_version_ 1797446559249465344
author Flavio Milana
Simone Famularo
Antonio Luberto
Lorenza Rimassa
Marta Scorsetti
Tiziana Comito
Tiziana Pressiani
Ciro Franzese
Dario Poretti
Luca Di Tommaso
Nicola Personeni
Marcello Rodari
Vittorio Pedicini
Matteo Donadon
Guido Torzilli
author_facet Flavio Milana
Simone Famularo
Antonio Luberto
Lorenza Rimassa
Marta Scorsetti
Tiziana Comito
Tiziana Pressiani
Ciro Franzese
Dario Poretti
Luca Di Tommaso
Nicola Personeni
Marcello Rodari
Vittorio Pedicini
Matteo Donadon
Guido Torzilli
author_sort Flavio Milana
collection DOAJ
description There is still debate over how reviewing oncological histories and addressing appropriate therapies in multidisciplinary team (MDT) discussions may affect patients’ overall survival (OS). The aim of this study was to describe MDT outcomes for a single cancer center’s patients affected by colorectal liver metastases (CRLMs). From 2010 to 2020, a total of 847 patients with CRLMs were discussed at our weekly MDT meeting. Patients’ characteristics and MDT decisions were analyzed in two groups: patients receiving systemic therapy (ST) versus patients receiving locoregional treatment (LRT). Propensity-score matching (PSM) was run to reduce the risk of selection bias. The median time from MDT indication to treatment was 27 (IQR 13–51) days. The median OS was 30 (95%CI = 27–34) months. After PSM, OS for patients undergoing LRT was 51 (95%CI = 36–64) months compared with 15 (95%CI = 13–20) months for ST patients (<i>p</i> < 0.0001). In this large retrospective study, the MDT discussions were useful in providing the patients with all available locoregional options.
first_indexed 2024-03-09T13:43:13Z
format Article
id doaj.art-64c26f68ed0d4f90996f32fef989519e
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T13:43:13Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-64c26f68ed0d4f90996f32fef989519e2023-11-30T21:04:23ZengMDPI AGCancers2072-66942022-08-011416395210.3390/cancers14163952Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 PatientsFlavio Milana0Simone Famularo1Antonio Luberto2Lorenza Rimassa3Marta Scorsetti4Tiziana Comito5Tiziana Pressiani6Ciro Franzese7Dario Poretti8Luca Di Tommaso9Nicola Personeni10Marcello Rodari11Vittorio Pedicini12Matteo Donadon13Guido Torzilli14Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, ItalyDepartment of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, ItalyDepartment of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, ItalyDepartment of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, ItalyRadiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, 20089 Rozzano, MI, ItalyRadiotherapy and Radiosurgery Department, IRCCS Humanitas Research Hospital, 20089 Rozzano, MI, ItalyHumanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Rozzano, MI, ItalyDepartment of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, ItalyDepartment of Radiology, IRCCS Humanitas Research Hospital, 20089 Rozzano, MI, ItalyDepartment of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, ItalyDepartment of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, ItalyDepartment of Nuclear Medicine, IRCCS Humanitas Research Hospital, 20089 Rozzano, MI, ItalyDepartment of Radiology, IRCCS Humanitas Research Hospital, 20089 Rozzano, MI, ItalyDepartment of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, ItalyDepartment of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, ItalyThere is still debate over how reviewing oncological histories and addressing appropriate therapies in multidisciplinary team (MDT) discussions may affect patients’ overall survival (OS). The aim of this study was to describe MDT outcomes for a single cancer center’s patients affected by colorectal liver metastases (CRLMs). From 2010 to 2020, a total of 847 patients with CRLMs were discussed at our weekly MDT meeting. Patients’ characteristics and MDT decisions were analyzed in two groups: patients receiving systemic therapy (ST) versus patients receiving locoregional treatment (LRT). Propensity-score matching (PSM) was run to reduce the risk of selection bias. The median time from MDT indication to treatment was 27 (IQR 13–51) days. The median OS was 30 (95%CI = 27–34) months. After PSM, OS for patients undergoing LRT was 51 (95%CI = 36–64) months compared with 15 (95%CI = 13–20) months for ST patients (<i>p</i> < 0.0001). In this large retrospective study, the MDT discussions were useful in providing the patients with all available locoregional options.https://www.mdpi.com/2072-6694/14/16/3952multidisciplinary team meetingcolorectal cancercolorectal liver metastases
spellingShingle Flavio Milana
Simone Famularo
Antonio Luberto
Lorenza Rimassa
Marta Scorsetti
Tiziana Comito
Tiziana Pressiani
Ciro Franzese
Dario Poretti
Luca Di Tommaso
Nicola Personeni
Marcello Rodari
Vittorio Pedicini
Matteo Donadon
Guido Torzilli
Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients
Cancers
multidisciplinary team meeting
colorectal cancer
colorectal liver metastases
title Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients
title_full Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients
title_fullStr Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients
title_full_unstemmed Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients
title_short Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients
title_sort multidisciplinary tumor board in the management of patients with colorectal liver metastases a single center review of 847 patients
topic multidisciplinary team meeting
colorectal cancer
colorectal liver metastases
url https://www.mdpi.com/2072-6694/14/16/3952
work_keys_str_mv AT flaviomilana multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT simonefamularo multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT antonioluberto multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT lorenzarimassa multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT martascorsetti multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT tizianacomito multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT tizianapressiani multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT cirofranzese multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT darioporetti multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT lucaditommaso multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT nicolapersoneni multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT marcellorodari multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT vittoriopedicini multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT matteodonadon multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients
AT guidotorzilli multidisciplinarytumorboardinthemanagementofpatientswithcolorectallivermetastasesasinglecenterreviewof847patients